Literature DB >> 24972770

Contribution of ADAMTS13 to the better cell engraftment efficacy in mouse model of bone marrow transplantation.

Hideto Matsui1, Maiko Takeda2, Kenji Soejima3, Yasunori Matsunari4, Shogo Kasuda5, Shiro Ono6, Kenji Nishio6, Midori Shima7, Fumiaki Banno8, Toshiyuki Miyata8, Mitsuhiko Sugimoto1.   

Abstract

Entities:  

Keywords:  ADAMTS13; bone marrow transplantation; cell engraftment; efficacy; mouse model

Mesh：

Substances：

Year:  2014        PMID： 24972770      PMCID： PMC4181274          DOI： 10.3324/haematol.2014.109512

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

Review 1.  Thrombotic thrombocytopenic purpura: advances in pathophysiology, diagnosis, and treatment--introduction.

Authors:  Bernhard Lämmle; James N George
Journal:  Semin Hematol       Date:  2004-01       Impact factor: 3.851

2.  Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura.

Authors:  Fumiaki Banno; Koichi Kokame; Tomohiko Okuda; Shigenori Honda; Shigeki Miyata; Hisashi Kato; Yoshiaki Tomiyama; Toshiyuki Miyata
Journal:  Blood       Date:  2005-12-20       Impact factor: 22.113

3.  'Green mice' as a source of ubiquitous green cells.

Authors:  M Okabe; M Ikawa; K Kominami; T Nakanishi; Y Nishimune
Journal:  FEBS Lett       Date:  1997-05-05       Impact factor: 4.124

4.  FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay.

Authors:  Koichi Kokame; Yuko Nobe; Yoshihiro Kokubo; Akira Okayama; Toshiyuki Miyata
Journal:  Br J Haematol       Date:  2005-04       Impact factor: 6.998

Review 5.  von Willebrand factor: two sides of a coin.

Authors:  J E Sadler
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

6.  ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage.

Authors:  Kenji Soejima; Masanori Matsumoto; Koichi Kokame; Hideo Yagi; Hiromichi Ishizashi; Hiroaki Maeda; Chikateru Nozaki; Toshiyuki Miyata; Yoshihiro Fujimura; Tomohiro Nakagaki
Journal:  Blood       Date:  2003-07-17       Impact factor: 22.113

7.  Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice.

Authors:  Simon F De Meyer; Alexander S Savchenko; Michael S Haas; Daphne Schatzberg; Michael C Carroll; Alexandra Schiviz; Barbara Dietrich; Hanspeter Rottensteiner; Friedrich Scheiflinger; Denisa D Wagner
Journal:  Blood       Date:  2012-08-22       Impact factor: 22.113

Review 8.  Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation.

Authors:  Shaji Kumar; Laurie D DeLeve; Patrick S Kamath; Ayalew Tefferi
Journal:  Mayo Clin Proc       Date:  2003-05       Impact factor: 7.616

Review 9.  Shear stress and von Willebrand factor in health and disease.

Authors:  Han-Mou Tsai
Journal:  Semin Thromb Hemost       Date:  2003-10       Impact factor: 4.180

10.  Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens.

Authors:  Lucienne M Ide; Bagirath Gangadharan; Kuang-Yueh Chiang; Christopher B Doering; H Trent Spencer
Journal:  Blood       Date:  2007-06-14       Impact factor: 22.113
View more
  1 in total

1.  Relevant role of von Willebrand factor in neutrophil recruitment in a mouse sepsis model involving cecal ligation and puncture.

Authors:  Shogo Kasuda; Hideto Matsui; Shiro Ono; Yasunori Matsunari; Kenji Nishio; Midori Shima; Katsuhiko Hatake; Mitsuhiko Sugimoto
Journal:  Haematologica       Date:  2015-10-22       Impact factor: 9.941
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.